WallachBeth Capital Starts Thermo Fisher Scientific (TMO) at Buy
Tweet Send to a FriendGet Alerts TMO Hot Sheet
Price: $86.27 +0.90%
Rating Summary:
12 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Rating Summary:
12 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Trade TMO Now!
WallachBeth Capital initiates coverage on Thermo Fisher Scientific (NYSE: TMO) with a Buy rating and $68 price target.
Analyst Peter McDonald comments, "TMO's AT business continues to benefit from new product introductions and the Dionex acquisition.TMO’s LPS business should benefit from recent restructuring and consumable demand, but will likely remain constrained given the funding environment. Over the next six months, we see two key headwinds; the uncertainty around academic and government funding (24% of revenue) and the uncertain economy. Its broad customer base helps offset potential academic segmentweakness, and the focus on operational efficiency, new product development, and share repurchases ($750MM) should enhance EPS growth whilea modest valuation (11x 2013e) provides some downside protection."
For an analyst ratings summary and ratings history on Thermo Fisher Scientific click here. For more ratings news on Thermo Fisher Scientific click here.
Shares of Thermo Fisher Scientific closed at $57.15 yesterday, with a 52 week range of $43.06-$58.37.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst Peter McDonald comments, "TMO's AT business continues to benefit from new product introductions and the Dionex acquisition.TMO’s LPS business should benefit from recent restructuring and consumable demand, but will likely remain constrained given the funding environment. Over the next six months, we see two key headwinds; the uncertainty around academic and government funding (24% of revenue) and the uncertain economy. Its broad customer base helps offset potential academic segmentweakness, and the focus on operational efficiency, new product development, and share repurchases ($750MM) should enhance EPS growth whilea modest valuation (11x 2013e) provides some downside protection."
For an analyst ratings summary and ratings history on Thermo Fisher Scientific click here. For more ratings news on Thermo Fisher Scientific click here.
Shares of Thermo Fisher Scientific closed at $57.15 yesterday, with a 52 week range of $43.06-$58.37.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Topeka Capital Starts Laredo Petroleum (LPI) at Buy, Assets 'Undervalued'
- Wunderlich Securities Starts Vertex Energy (VTNR) at Buy
- WallachBeth Capital Starts NuVasive (NUVA) at Buy
Create E-mail Alert Related Categories
New Coverage
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
